{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:07:33Z","timestamp":1788905253218,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["ANHRF111-21"],"award-info":[{"award-number":["ANHRF111-21"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["NHRI-108A1-CACO-13191902"],"award-info":[{"award-number":["NHRI-108A1-CACO-13191902"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.htct.2026.106519","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:05:09Z","timestamp":1788591909000},"page":"106519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B virus reactivation risk in haploidentical versus matched donor transplantation: Impact of universal prophylaxis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-7711","authenticated-orcid":false,"given":"Tzu-Ting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Peng","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-6389","authenticated-orcid":false,"given":"Ching-Chan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106519_bib0001","article-title":"Management of hepatitis B virus in allogeneic hematopoietic stem cell transplantation recipients","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"21","key":"10.1016\/j.htct.2026.106519_bib0002","first-page":"5527","article-title":"Hepatitis B virus infection in patients receiving allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Gentile","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.htct.2026.106519_bib0003","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood.V99.7.2324","article-title":"High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation","volume":"99","author":"Lau","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.htct.2026.106519_bib0004","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/v17030388","article-title":"HBV reactivation in immunosuppressed patients: screening, prevention, and management including solid organ transplant recipients","volume":"17","author":"Vutien","year":"2025","journal-title":"Viruses"},{"issue":"17","key":"10.1016\/j.htct.2026.106519_bib0005","article-title":"Risk factors of HBV reactivation in leukemia patients with resolved HBV infection after allogeneic hematopoietic stem cell transplantation: a large-scale study","volume":"13","author":"Huang","year":"2024","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.htct.2026.106519_bib0006","first-page":"117","article-title":"ESCMID study group for infections in compromised hosts (ESGICH). Prophylaxis of hepatitis B virus (HBV) infection reactivation","volume":"23","author":"Mikulska","year":"2019","journal-title":"Contemp Oncol (Pozn)"},{"issue":"2","key":"10.1016\/j.htct.2026.106519_bib0007","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2024.11.008","article-title":"AGA clinical practice guideline on the prevention and treatment of Hepatitis B virus reactivation in At-risk individuals","volume":"168","author":"Ali","year":"2025","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.htct.2026.106519_bib0008","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"31","key":"10.1016\/j.htct.2026.106519_bib0009","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1200\/JCO.20.01757","article-title":"Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO provisional clinical opinion update","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.htct.2026.106519_bib0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1473-3099(16)00118-3","volume":"16","author":"Mallet","year":"2016","journal-title":"Lancet Infect Dis."},{"issue":"5","key":"10.1016\/j.htct.2026.106519_bib0011","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/S2352-3026(25)00049-3","volume":"12","author":"Mikulska","year":"2025","journal-title":"Lancet Haematol"},{"issue":"33","key":"10.1016\/j.htct.2026.106519_bib0012","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.3748\/wjg.v29.i33.4942","article-title":"Prevention and management of hepatitis B virus reactivation in cancer patients","volume":"29","author":"Chen","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"23","key":"10.1016\/j.htct.2026.106519_bib0013","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant cyclophosphamide is associated with increased non-cytomegalovirus infections","volume":"137","author":"Ciurea","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.htct.2026.106519_bib0014","first-page":"405","article-title":"Randomized phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies","volume":"37","author":"Luznik","year":"2019","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.htct.2026.106519_bib0015","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.18632\/oncotarget.24328","article-title":"Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs. anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell haploidentical transplantation","volume":"9","author":"Reti\u00e8re","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.htct.2026.106519_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2040620717741860","article-title":"New and emerging therapies for acute and chronic graft versus host disease","volume":"9","author":"Hill","year":"2018","journal-title":"Ther Adv Hematol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792600266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792600266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:15:10Z","timestamp":1788902110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253113792600266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S253113792600266X"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106519","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus reactivation risk in haploidentical versus matched donor transplantation: Impact of universal prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}],"article-number":"106519"}}